Ewan Livesey

Ewan Livesey has a vast work experience spanning multiple companies and roles. Ewan is currently the Co-Founder and CEO of Nucleo since June 2021. In addition, they are also working as a Business Development Consultant at Flynn Pharma and as a Member of the Board of Advisors at SYNAP IoT, both starting in June 2022.

Before their current roles, Ewan founded and served as the Managing Director of Birnam Oak since October 2018. Ewan also worked as the Interim Chief Business Development Officer at Norgine from May 2021 to May 2022.

Prior to that, Ewan held positions such as the Head of Corporate Development at Zentiva from January 2019 to June 2020, the Chief Business Officer at Apotex Inc. from September 2016 to September 2018, and the Senior Vice President Corporate Development: Europe, Country Manager: Switzerland at Lupin Atlantis Holdings SA from January 2011 to August 2016.

Earlier in their career, Ewan worked as the Executive Vice President Corporate Development at Glenmark Pharmaceuticals Europe from May 2006 to October 2010, and as the Vice President - Legal Affairs at IVAX Europe from May 1995 to April 2006.

Ewan Livesey's education history begins in 1987 when they attended Queen Mary University of London. Ewan obtained a Bachelor of Laws (LLB Hons) degree from there, graduating in 1990. Following this, they pursued a Dip EU Law degree from King's College London, specializing in European Union Law. This happened during the academic year of 1993-1994. In 1991, they attended the College of Law in Lancaster Gate, London, where they completed their Law Society Finals in 1992.